Evidence map›Paper›PMID 34458585›Full record

ArticleTranslational medicine communications2021

Correction to: Mesenchymal stem cells in the treatment of severe COVID-19.

Santosh Kesari, Gregory C Kasper, Lev Verkh, Terese C Hammond, Marla L Matal, Jay W Hammerling, Nikolai Tankovich, Adrianus P Lim, Kevin H Zhao, Tiffany Juarez and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational medicine communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Santosh KesariPacific Neuroscience Institute and Providence Saint John's Health Center, Santa Monica, USA.
Gregory C KasperProMedica Toledo Hospital, 2142 North Cove Blvd, Toledo, OH 43606 USA.
Lev VerkhStemedica Cell Technologies, Inc., San Diego, USA.
Terese C HammondProvidence Saint John's Health Center, Santa Monica, USA.
Marla L MatalProMedica Toledo Hospital, 2142 North Cove Blvd, Toledo, OH 43606 USA.
Jay W HammerlingProMedica Toledo Hospital, 2142 North Cove Blvd, Toledo, OH 43606 USA.
Nikolai TankovichStemedica Cell Technologies, Inc., San Diego, USA.
Adrianus P LimProMedica Toledo Hospital, 2142 North Cove Blvd, Toledo, OH 43606 USA.
Kevin H ZhaoProMedica Toledo Hospital, 2142 North Cove Blvd, Toledo, OH 43606 USA.
Tiffany JuarezPacific Neuroscience Institute and Providence Saint John's Health Center, Santa Monica, USA.
Roberta E RedfernProMedica Toledo Hospital, 2142 North Cove Blvd, Toledo, OH 43606 USA.
Jaya M GillPacific Neuroscience Institute, Santa Monica, USA.
Natsuko NomuraPacific Neuroscience Institute and Providence Saint John's Health Center, Santa Monica, USA.
Audrey HiemerPacific Neuroscience Institute and Providence Saint John's Health Center, Santa Monica, USA.
Annie HengPacific Neuroscience Institute and Providence Saint John's Health Center, Santa Monica, USA.
Jessica ShoemakerProMedica Toledo Hospital, 2142 North Cove Blvd, Toledo, OH 43606 USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1186/s41231-021-00095-0.].

Identifiers

PMID34458585
PMCPMC8381133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.